KRISTEN VAN STAALDUINEN: Open Payments
NPI 1578010740 · WAYNESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 67 payments from 11 companies in 2025. Trend: 2023 $480 · 2024 $573 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $388 |
| Lilly USA, LLC | 11 | $192 |
| Novo Nordisk Inc | 6 | $101 |
| Exact Sciences Corporation | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Merck Sharp & Dohme LLC | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, MOUNJARO, Cologuard Collection Kit, Ozempic, QULIPTA, REXULTI, TRELEGY ELLIPTA, ZEPBOUND.
Industry payments across OH — which companies pay providers there.
